NEO: Rega marang dodolan NeoGenomics Laboratories
NeoGenomics, Inc. (NEO) is upgrading its equipment to accelerate diagnostics without operational downtime. Management is implementing a process optimization strategy to drive margin growth and foster partnerships with pharmaceutical behemoths. The company's current P/S ratio illustrates the business valuation trend, where the 2.70 metric determines this level. The high status of its research and generous bonuses enable the recruitment of leading oncology specialists, as this chart confirms.
Rincian analitis perusahaan NeoGenomics Laboratories (NEO)
- nilai pasar lan prakiraan target analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas NeoGenomics, Inc.|NEO - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal NeoGenomics Corp|NEO - Gunggung utang perusahaan|Utang marang nilai buku NeoGenomics Laboratories|NEO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak NeoGenomics|Rasio jangkoan perantara neogenomics.com
- indikator pendapatan resik lan kelipatan nilai:
NEO - Bathi resik|Prakiraan bathi perusahaan NeoGenomics, Inc.|NEO - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep NeoGenomics Inc|NEO - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NeoGenomics Laboratories|NEO - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan NeoGenomics|NEO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan neogenomics.com|NEO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep NeoGenomics, Inc.
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:NEO (neogenomics.com)
To filter for high-quality assets, investors utilize a comparative analysis of market value and actual cash flows. This price-to-sales ratio compares the market capitalization of NeoGenomics, Inc. (NEO) with its annual sales volume, allowing for an assessment of the extent to which the market is overpaying for the company's exceptional authority in cancer diagnostics and its unique portfolio of genetic tests, as clearly reflected in the chart's price action.
Pesaing NeoGenomics, Inc.
linde.com (LIN) - Multiplikator rega marang pendapatan|Multiplikator P/S APD (Air Products and Chemicals)|DuPont de Nemours (DD) - Rega marang dodolan|IP - Rasio rega marang pendapatan|PPG (PPG Industries, Inc.) - Rasio kapitalisasi marang pendapatan|Dow Inc. (DOW) - Rasio rega marang pendapatan|Rega marang dodolan lyondellbasell.com (LYB)|Rasio rega marang pendapatan International Flavors & Fragrances Inc|Kapitalisasi marang pendapatan RPM International Inc (RPM)|Multiplikator P/S ENTG|Koefisien rega marang pendapatan Suzano Group|Multiplikator P/S WLK (Westlake Corporation)|ALB - Kapitalisasi marang pendapatan|ICL - Rasio rega marang pendapatan|Koefisien rega marang pendapatan NewMarket Corp NEU|EMN (Eastman Chemical Corp) - Kapitalisasi marang pendapatan|Axalta Corp - Rasio kapitalisasi pasar marang pendapatan|ESI (Element Solutions Inc) - Multiplikator P/S|sqm.com (SQM) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Celanese (CE)|Sensient Technologies Corporation - Rasio kapitalisasi marang pendapatan|Multiplikator P/S CBT (Cabot Microelectronics)|HWKN - Kapitalisasi marang pendapatan|AVNT: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan hbfuller.com FUL|Methanex (MEOH) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan WDFC|CC (Chemours Corp) - Multiplikator P/S|Rega marang dodolan Quaker Chemical Corp. KWR|Rasio rega marang pendapatan PureCycle Technologies (PCT)|ASH - Rega marang dodolan|Multiplikator P/S NGVT (Ingevity)|IOSP - Kapitalisasi marang pendapatan|Minerals Tech - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan DQ (Daqo Solar)|SLVM: Multiplikator P/S|Rega marang dodolan huntsman.com (HUN)|Rasio rega marang pendapatan Albany International Corp.|Kapitalisasi marang pendapatan Calumet Specialty Products Partners, L.P. (CLMT)|Multiplikator P/S ROG|Koefisien rega marang pendapatan Stepan Chemical|Rasio rega marang pendapatan Ecovyst Inc. ECVT|Koefisien rega marang pendapatan rexamerican.com (REX)|ASPI: Kapitalisasi marang pendapatan|Tronox Holdings - Kapitalisasi marang volume dodolan|Ferroglobe Corp (GSM) - Rasio rega marang pendapatan|Westlake Partners - Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CMP|Rega marang dodolan kronostio2.com KRO|Rasio rega marang pendapatan Mativ (MATV)|LSB Industries Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BAK (Braskem Group)|Koppers Corp (KOP) - Rega marang dodolan|ASIX - Rasio rega marang pendapatan|Rega marang dodolan orioncarbons.com|RYAM: Multiplikator P/S|Multiplikator rega marang pendapatan Aduro Clean Tech ADUR|MAGN (Magnera Inc.) - Multiplikator P/S|Rega marang dodolan Clearwater Paper Corp. CLW|Rasio rega marang pendapatan Tredegar Corporation (TG)|coremt.com - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan FutureFuel FF|Flexible Solutions International Inc. (FSI) - Rega marang dodolan|ALTO - Rasio rega marang pendapatan|5E Advanced Materials (FEAM) - Kapitalisasi marang pendapatan|TSE: Multiplikator P/S|ORGN - Koefisien rega marang pendapatan|NTIC (Northern Technologies International) - Multiplikator P/S|Kapitalisasi marang pendapatan LanzaTech Global (LNZA)|Rasio rega marang pendapatan J-Star Holding Co Ltd (YMAT)|Koefisien rega marang pendapatan newerahelium.com|Bolt Projects Holdings - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan BGLC|Gulf Resources - Multiplikator P/S|Koefisien rega marang pendapatan CN Energy Group. Inc. CNEY|arcadiumlithium.com (ALTM) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan DNMR|GLT (Glatfelter Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Graphex (GRFX)|Kapitalisasi marang pendapatan SLCA (U.S. Silica)|Koefisien rega marang pendapatan Invizyne Technologies Inc
